From: PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression
Tumors | Type | Methods | Expression | References |
---|---|---|---|---|
HCC | Primary HCC | IHC | 15/16a | [9] |
HCC tissues and cell lines | cDNA microarray | Significantly higher | [16] | |
HCC cell lines | QPCR | 18/20b | [17] | |
Primary HCC | QPCR | Significantly higher | ||
HCC tissues | IHC | 148/218a | [19] | |
Pancreatic carcinoma | Pancreatic carcinoma tissues | IHC | 85/160b | [20] |
Breast cancer | Ductal carcinoma | IHC | 6/11a | [10] |
Invasive ductal carcinomas | IHC | 7/22a | ||
Breast cancer tissue (n = 161) | IHC | 36%a | ||
Prostate cancer | Prostate cancer tissue (n = 30) | IHC | 37%a | [10] |
Gallbladder carcinoma | Gallbladder adenocarcinoma tissues | IHC | 52/108a | [21] |
Thyroid cancer | 24 thyroid cancer tissues and 14 normal thyroid tissues | QPCR | Significantly higher (P = 0.034) | [22] |
OSCC | OSCC tissues | QPCR | 83/118b | [23] |
Colon cancer | Colon cancer tissues | QPCR and WB | 9/20a | [24] |
Enchondromas | Enchondromas tissues | IHC and QPCR | Strongly positive expression | [25] |
B-CLL | B-CLL PBMNCs | QPCR | 40/42b | [26] |